Wellcome unveils details of £200M fund
This article was originally published in Scrip
Executive Summary
Trailed initially last Spring (ScripIntelligence, 20 March 2012), The Wellcome Trust has revealed more details of its new £200 million fund which is being launched as Syncona Partners LLP. A return-driven evergreen investment company, Syncona intends to support the creation of sustainable healthcare businesses, focusing on therapeutics, diagnostics or medical devices, investing between £1 million to £20 million, both as a majority investor or as part of a syndicate.